ZVSA Shares Outstanding History — ZyVersa Therapeutics Share Count Over Time

As of 5/11/2026 ZyVersa Therapeutics has 8.10 million ZVSA shares outstanding. Investors often track the ZVSA shares outstanding history to compare shareholder return trends against the change in share count over time.

This page shows ZVSA share count trends over time, with 9 historical shares outstanding datapoints presented, dating back to 5/10/2024.

Quick links: Shares Outstanding History Table  |  Shares Outstanding History Chart  |  About ZyVersa Therapeutics
ZVSA Shares Outstanding History



Below is a table of the ZVSA shares outstanding history going back to 5/10/2024:

Date ZVSA Shares Outstanding
5/10/2024834896
8/8/20241.03M
11/11/20242.34M
3/20/20252.57M
5/7/20254.77M
8/7/20258.10M
11/17/20258.10M
3/25/20268.10M
5/11/20268.10M

Also see: ZVSA Market Cap History
ZVSA YTD Return
ZVSA Historical Shares Outstanding:
+210.92% CAGR
ZVSA Historical Shares Outstanding: +210.92% CAGR

Mouse over chart for data details
5/10/2024 ...5/11/2026
ZyVersa Therapeutics is a clinical stage specialty biopharmaceutical company with two licensed proprietary product platforms. Co.'s focus is on renal and inflammatory diseases. The lead candidate in Co.'s renal pipeline is a Phase 2a-ready cholesterol efflux mediator, VAR 200, for focal segmental glomerulosclerosis (FSGS), an orphan renal disease. VAR 200 mediates removal of excess renal cholesterol and lipids that damage the kidneys and has potential to reduce proteinuria and delay disease progression. For treatment of inflammatory diseases, Co. is developing a monoclonal antibody that inhibits inflammasome ASC (IC 100). We show 9 historical shares outstanding datapoints in our coverage of ZVSA's shares outstanding history.

Understanding the changing numbers of ZVSA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ZVSA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ZVSA by allowing them to research ZVSA shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ZVSA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance
ZyVersa Therapeutics (ZVSA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ZY Shares Outstanding History
ZYME Shares Outstanding History
ZYNE Shares Outstanding History
ZYXI Shares Outstanding History
A Shares Outstanding History
AAC Shares Outstanding History
AADI Shares Outstanding History
AARD Shares Outstanding History
ABAX Shares Outstanding History
ABBV Shares Outstanding History
More Healthcare companies »
 

ZVSA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.